Passage BIO, Inc.

PASG · Nasdaq · SIC 2836: Biological Products, (No Diagnostic Substances)
118
SEC Filings

Business Summary

PARTI Overview We are a clinical stage genetic medicines company focused on improving the lives of patients with neurodegenerative diseases. Our primary focus is the development and advancement of cutting-edge, one-time gene therapies designed to target critical underlying pathologies in these conditions. We believe we have developed a differentiated approach to developing treatments for central nervous system, or CNS, disorders that allows us to select and advance product candidates with a high...

Next Earnings

Q2 FY2026 — expected 2026-09-13

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionPASGdiscussed_in_filing Artificial Intelligence
topic_mentionPASGdiscussed_in_filing Cybersecurity
topic_mentionPASGdiscussed_in_filing Trusted Computing
topic_mentionPASGdiscussed_in_filing Blockchain & Crypto
topic_mentionPASGdiscussed_in_filing Capital Expenditure
topic_mentionPASGdiscussed_in_filing Supply Chain
topic_mentionPASGdiscussed_in_filing Regulation
topic_mentionPASGdiscussed_in_filing Automotive
topic_mentionPASGdiscussed_in_filing Healthcare & Bio
topic_mentionPASGdiscussed_in_filing Sovereign & Government
topic_mentionPASGdiscussed_in_filing Artificial Intelligence
topic_mentionPASGdiscussed_in_filing Cybersecurity
topic_mentionPASGdiscussed_in_filing Trusted Computing
topic_mentionPASGdiscussed_in_filing Blockchain & Crypto
topic_mentionPASGdiscussed_in_filing Capital Expenditure
topic_mentionPASGdiscussed_in_filing Supply Chain
topic_mentionPASGdiscussed_in_filing Regulation
topic_mentionPASGdiscussed_in_filing Automotive
topic_mentionPASGdiscussed_in_filing Healthcare & Bio
topic_mentionPASGdiscussed_in_filing Sovereign & Government

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-032025-12-310001104659-26-022549EDGAR91K words
2025-03-042024-12-310001558370-25-002101EDGAR—
2024-03-042023-12-310001558370-24-002310EDGAR—
2023-03-062022-12-310001558370-23-002833EDGAR—
2022-03-032021-12-310001558370-22-002719EDGAR—
2021-03-032020-12-310001558370-21-002287EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-102025-09-300001104659-25-109180EDGAR66K words
2025-08-122025-06-300001558370-25-011146EDGAR—
2025-05-132025-03-310001558370-25-007489EDGAR—
2024-11-132024-09-300001558370-24-015431EDGAR—
2024-08-082024-06-300001558370-24-011463EDGAR—
2024-05-142024-03-310001558370-24-008058EDGAR—
2023-11-132023-09-300001558370-23-018686EDGAR—
2023-08-072023-06-300001558370-23-013489EDGAR—
2023-05-112023-03-310001558370-23-009256EDGAR—
2022-11-102022-09-300001558370-22-017285EDGAR—
2022-08-042022-06-300001558370-22-012042EDGAR—
2022-05-162022-03-310001558370-22-008859EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-03-100001104659-26-025550EDGAR1K words
2026-03-030001104659-26-022539EDGAR—
2026-01-120001104659-26-002696EDGAR—
2025-11-100001104659-25-109158EDGAR—
2025-09-180001104659-25-091288EDGAR—
2025-08-120001558370-25-011143EDGAR—
2025-07-290001104659-25-071779EDGAR—
2025-07-140001104659-25-067561EDGAR—
2025-06-230001104659-25-061371EDGAR—
2025-05-300001104659-25-054907EDGAR—

118 total filings indexed. 90 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

FDMT — 4D Molecular Therapeutics, Inc. APTN — ADAPTIN BIO, INC. ADMA — ADMA BIOLOGICS, INC. AGEN — AGENUS INC AIM — AIM ImmunoTech Inc. AMGN — AMGEN INC AVXL — ANAVEX LIFE SCIENCES CORP. ABPO — Abpro Holdings, Inc.

Company Identity

CIK0001787297
TickerPASG
ExchangeNasdaq
SIC2836: Biological Products, (No Diagnostic Substances)
IncorporatedDE

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 37ca99fb3bbaa71fd167b02bc4893f0f66141f154e3c34320d9baff0b9d9c26b
parent: f408dba6a9036b1893af04ae8d88ee6ac3d95d77fbe04d4d0c11001b1845ee0c
content hash: 8f61e818e4f624766d1c91a0e03e1434ee40753f0a234753d957fe12dfca8662
signed: 2026-04-13T04:46:48.739Z
sources: 18 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf